Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Prevalence estimates of use of cancer screening tests among American Indian/Alaska Native and non-Hispanic White adults resident in CHSDA counties—Behavioral Risk Factor Surveillance System, 2000–2006a

 NHW TotalaAI/AN TotalaNorthern PlainsbAlaskacSouthern PlainsdPacific CoasteEastfSouthwestg
%h(95% CI)%(95% CI)%(95% CI)%(95% CI)%(95% CI)%(95% CI)%(95% CI)%(95% CI)
Mammography within 2 years, women aged 40+i
 76.0(75.5–76.5)68.7(64.7–72.4)73.9(67.8–79.3)75.9(69.6–81.2)71.3(66.2–76.0)63.3(52.3–73.1)70.7(59.7–79.7)65.0(58.4–71.0)
Papanicolaou (Pap) test within 3 years women without hysterectomyi
 83.7(83.3–84.1)79.3(76.4–82.0)83.3(79.1–86.8)87.5(84.5–90.1)77.7(73.7–81.3)76.4(69.1–82.4)74.9(64.7–82.9)80.1(76.4–83.4)
Prostate specific antigen test within 1 year, men aged 50–75j
 53.0(52.3–53.6)44.4(39.2–49.7)50.0(42.4–57.6)34.8(27.8–42.5)45.4(40.1–50.7)45.4(35.2–56.1)43.4(34.0–53.4)41.6(35.9–47.5)
Fecal occult blood test within 1 year or endoscopy within 5 years, aged 50+j
All54.3(53.8–54.8)40.2(35.5–45.0)36.0(29.1–43.5)49.4(42.8–56.1)42.4(38.1–46.9)41.1(31.5–51.5)41.3(32.5–50.7)33.8(28.8–39.1)
Male56.0(55.2–56.8)39.6(32.7–47.0)26.0(18.4–35.4)42.9(33.6–52.6)46.4(39.5–53.5)45.9(32.3–60.2)29.8(19.9–42.1)33.6(26.1–42.0)
Female53.1(52.4–53.8)41.4(35.9–47.1)45.2(36.2–54.6)55.1(46.0–63.8)38.8(33.6–44.3)40.0(27.8–53.6)53.5(41.7–64.9)33.9(27.6–40.8)

CHSDA indicates Contract Health Service Delivery Areas of the Indian Health Service; NHW, non-Hispanic whites; AI/AN, American Indians/Alaska Natives; 95% CI, 95% confidence interval.

a Data from 33 U.S. states (includes states listed in the footnotes below).
b AI/AN in Indiana, Iowa, Michigan, Minnesota, Montana, Nebraska, North Dakota, South Dakota, Wisconsin, and Wyoming.
c AI/AN in Alaska.
d AI/AN in Kansas, Oklahoma, and Texas.
e AI/AN in California, Idaho, Oregon, and Washington.
f AI/AN in Alabama, Connecticut, Florida, Louisiana, Maine, Massachusetts, Mississippi, New York, North Carolina, Rhode Island, and South Carolina.
g AI/AN in Arizona, Colorado, Nevada, New Mexico, and Utah.
h All prevalence estimates are weighted and age-adjusted to the 2000 US standard population. “Refused” and “don’t know” responses are excluded.
i 2000, 2002, 2004, and 2006 (AI/AN estimates do not include Massachusetts).
j 2001, 2002, 2004, and 2006 (AI/AN estimates do not include Massachusetts).

Download table formatted for print (PDF-36KB)

Top